Profile | GDS4284 / 235303_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 515.537 | 64 |
GSM687648 | Patient 402 control | 415.92 | 61 |
GSM687653 | Patient 403 control | 400.481 | 61 |
GSM687658 | Patient 404 control | 432.308 | 61 |
GSM687663 | Patient 411 control | 523.43 | 64 |
GSM687668 | Patient 422 control | 380.3 | 60 |
GSM687673 | Patient 424 control | 309.934 | 55 |
GSM687678 | Patient 425 control | 488.006 | 62 |
GSM687683 | Patient 427 control | 369.935 | 57 |
GSM687688 | Patient 428 control | 684.708 | 68 |
GSM687695 | Patient 441 control | 182.879 | 37 |
GSM687699 | Patient 443 control | 210.232 | 46 |
GSM687704 | Patient 444 control | 544.119 | 65 |
GSM687707 | Patient 448 control | 365.39 | 58 |
GSM687712 | Patient 449 control | 220.75 | 50 |
GSM687719 | Patient 450 control | 639.135 | 66 |
GSM687724 | Patient 451 control | 367.323 | 59 |
GSM687728 | Patient 452 control | 450.329 | 62 |
GSM687646 | Patient 401 treated 24h | 555.088 | 64 |
GSM687649 | Patient 402 treated 24h | 430.22 | 61 |
GSM687665 | Patient 411 treated 24h | 416.106 | 60 |
GSM687651 | Patient 402 treated 4 weeks | 417.795 | 60 |
GSM687667 | Patient 411 treated 4 weeks | 489.75 | 63 |
GSM687670 | Patient 422 treated 24h | 368.187 | 58 |
GSM687671 | Patient 422 treated 4 weeks | 480.528 | 63 |
GSM687654 | Patient 403 treated 24h | 492.239 | 64 |
GSM687675 | Patient 424 treated 24h | 351.787 | 57 |
GSM687685 | Patient 427 treated 24h | 393.187 | 60 |
GSM687656 | Patient 403 treated 4 weeks | 453.289 | 63 |
GSM687677 | Patient 424 treated 4 weeks | 300.412 | 55 |
GSM687687 | Patient 427 treated 4 weeks | 516.789 | 64 |
GSM687692 | Patient 428 treated 4h | 645.044 | 67 |
GSM687716 | Patient 449 treated 4h | 222.609 | 51 |
GSM687722 | Patient 450 treated 4h | 531.507 | 64 |
GSM687680 | Patient 425 treated 24h | 409.055 | 60 |
GSM687690 | Patient 428 treated 24h | 614.874 | 67 |
GSM687700 | Patient 443 treated 24h | 356.143 | 54 |
GSM687705 | Patient 444 treated 24h | 397.803 | 61 |
GSM687714 | Patient 449 treated 24h | 359.023 | 59 |
GSM687721 | Patient 450 treated 24h | 604.917 | 66 |
GSM687682 | Patient 425 treated 4 weeks | 295.71 | 56 |
GSM687694 | Patient 428 treated 4 weeks | 764.909 | 70 |
GSM687702 | Patient 443 treated 4 weeks | 375.542 | 58 |
GSM687718 | Patient 449 treated 4 weeks | 297.067 | 56 |
GSM687723 | Patient 450 treated 4 weeks | 527.156 | 64 |
GSM687661 | Patient 404 treated 4h | 399.051 | 60 |
GSM687710 | Patient 448 treated 4h | 487.635 | 64 |
GSM687726 | Patient 451 treated 4h | 423.4 | 60 |
GSM687730 | Patient 452 treated 4h | 314.377 | 42 |
GSM687660 | Patient 404 treated 24h | 275.128 | 51 |
GSM687697 | Patient 441 treated 24h | 256.532 | 48 |
GSM687709 | Patient 448 treated 24h | 453.604 | 62 |
GSM687725 | Patient 451 treated 24h | 257.42 | 50 |
GSM687729 | Patient 452 treated 24h | 297.234 | 52 |
GSM687727 | Patient 451 treated 4 weeks | 309.193 | 54 |
GSM687731 | Patient 452 treated 4 weeks | 357.183 | 57 |